Nifty
Sensex
:
:
17739.85
60384.62
-24.75 (-0.14%)
-122.28 (-0.20%)

Pharmaceuticals & Drugs - Global

Rating :
63/99

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 52,113.83
  • 63.13
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 55,728.52
  • 1.56%
  • 8.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 0.36%
  • 4.72%
  • FII
  • DII
  • Others
  • 12.09%
  • 8.32%
  • 3.26%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.23
  • 7.42
  • 2.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.39
  • 12.50
  • 2.30

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.03
  • 2.76
  • -8.80

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 37.10
  • 41.67
  • 41.04

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.92
  • 7.19
  • 8.10

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.94
  • 19.21
  • 20.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Net Sales
2,491.00
2,108.00
18.17%
2,291.00
2,137.00
7.21%
2,347.00
2,134.00
9.98%
2,131.00
1,937.00
10.02%
Expenses
1,767.00
1,570.00
12.55%
1,612.00
1,477.00
9.14%
1,635.00
1,457.00
12.22%
1,570.00
1,355.00
15.87%
EBITDA
724.00
538.00
34.57%
679.00
660.00
2.88%
712.00
677.00
5.17%
561.00
582.00
-3.61%
EBIDTM
29.06%
25.52%
29.64%
30.88%
30.34%
31.72%
26.33%
30.05%
Other Income
-10.00
48.00
-
16.00
51.00
-68.63%
30.00
40.00
-25.00%
56.00
39.00
43.59%
Interest
102.00
62.00
64.52%
69.00
71.00
-2.82%
55.00
68.00
-19.12%
57.00
73.00
-21.92%
Depreciation
193.00
167.00
15.57%
163.00
168.00
-2.98%
155.00
165.00
-6.06%
162.00
165.00
-1.82%
PBT
419.00
357.00
17.37%
463.00
472.00
-1.91%
532.00
484.00
9.92%
-87.00
383.00
-
Tax
136.00
108.00
25.93%
151.00
156.00
-3.21%
178.00
154.00
15.58%
31.00
59.00
-47.46%
PAT
283.00
249.00
13.65%
312.00
316.00
-1.27%
354.00
330.00
7.27%
-118.00
324.00
-
PATM
11.36%
11.81%
13.62%
14.79%
15.08%
15.46%
-5.54%
16.73%
EPS
8.36
7.36
13.59%
9.22
9.34
-1.28%
10.46
9.75
7.28%
-3.49
9.57
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
9,260.00
8,508.04
8,004.57
7,939.31
7,672.80
5,949.83
5,815.69
6,666.85
4,653.45
4,184.72
3,211.14
Net Sales Growth
11.35%
6.29%
0.82%
3.47%
28.96%
2.31%
-12.77%
43.27%
11.20%
30.32%
 
Cost Of Goods Sold
2,653.00
2,230.75
1,960.12
1,981.79
2,041.26
1,535.17
1,629.66
1,432.13
1,280.96
1,107.58
807.98
Gross Profit
6,607.00
6,277.29
6,044.45
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
GP Margin
71.35%
73.78%
75.51%
75.04%
73.40%
74.20%
71.98%
78.52%
72.47%
73.53%
74.84%
Total Expenditure
6,584.00
6,076.77
5,524.49
5,768.95
5,696.31
4,600.58
4,438.42
3,937.05
3,633.29
3,233.24
2,518.92
Power & Fuel Cost
-
144.19
122.94
128.19
132.46
118.77
107.98
92.59
97.41
71.88
62.80
% Of Sales
-
1.69%
1.54%
1.61%
1.73%
2.00%
1.86%
1.39%
2.09%
1.72%
1.96%
Employee Cost
-
1,526.45
1,439.62
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
741.10
623.29
% Of Sales
-
17.94%
17.98%
18.00%
18.30%
19.08%
17.08%
12.63%
18.09%
17.71%
19.41%
Manufacturing Exp.
-
591.13
550.92
544.11
558.84
457.58
502.16
353.45
345.98
320.78
278.15
% Of Sales
-
6.95%
6.88%
6.85%
7.28%
7.69%
8.63%
5.30%
7.43%
7.67%
8.66%
General & Admin Exp.
-
637.65
633.48
801.98
763.90
677.71
578.05
637.92
463.28
398.98
324.55
% Of Sales
-
7.49%
7.91%
10.10%
9.96%
11.39%
9.94%
9.57%
9.96%
9.53%
10.11%
Selling & Distn. Exp.
-
884.91
742.63
807.39
738.03
641.30
567.70
547.05
574.40
461.53
393.07
% Of Sales
-
10.40%
9.28%
10.17%
9.62%
10.78%
9.76%
8.21%
12.34%
11.03%
12.24%
Miscellaneous Exp.
-
61.69
74.78
76.45
58.03
34.80
59.46
31.56
29.45
131.39
393.07
% Of Sales
-
0.73%
0.93%
0.96%
0.76%
0.58%
1.02%
0.47%
0.63%
3.14%
0.91%
EBITDA
2,676.00
2,431.27
2,480.08
2,170.36
1,976.49
1,349.25
1,377.27
2,729.80
1,020.16
951.48
692.22
EBITDA Margin
28.90%
28.58%
30.98%
27.34%
25.76%
22.68%
23.68%
40.95%
21.92%
22.74%
21.56%
Other Income
92.00
196.56
56.91
121.30
63.62
298.84
223.30
228.80
285.55
38.13
43.36
Interest
283.00
255.06
352.94
450.71
503.75
308.48
205.56
183.98
175.16
58.63
33.80
Depreciation
673.00
662.16
657.79
654.38
617.69
408.60
306.92
237.55
190.74
87.00
82.69
PBT
1,327.00
1,710.61
1,526.26
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
843.98
619.09
Tax
496.00
448.73
274.38
161.85
125.35
252.87
154.51
610.17
188.84
180.07
146.69
Tax Rate
37.38%
36.60%
17.98%
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
PAT
831.00
777.18
1,251.88
1,024.72
436.28
678.11
933.55
1,733.24
750.94
663.88
432.76
PAT before Minority Interest
831.00
777.18
1,251.88
1,024.72
436.31
678.14
933.58
1,733.27
750.97
663.91
434.91
Minority Interest
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
PAT Margin
8.97%
9.13%
15.64%
12.91%
5.69%
11.40%
16.05%
26.00%
16.14%
15.86%
13.48%
PAT Growth
-31.83%
-37.92%
22.17%
134.88%
-35.66%
-27.36%
-46.14%
130.81%
13.11%
53.41%
 
EPS
24.56
22.97
36.99
30.28
12.89
20.04
27.59
51.22
22.19
19.62
12.79

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
5,952.95
5,837.17
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
Share Capital
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
42.31
Total Reserves
5,868.33
5,752.55
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
Non-Current Liabilities
2,238.15
2,924.20
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
Secured Loans
2,123.22
2,941.07
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
Unsecured Loans
0.00
0.00
1.56
3.11
6.15
11.26
10.62
13.62
13.74
51.35
Long Term Provisions
368.74
369.62
338.34
288.52
286.66
263.04
246.36
207.49
190.43
129.51
Current Liabilities
4,415.09
4,891.62
5,454.16
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
Trade Payables
1,674.44
2,066.81
2,048.81
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
Other Current Liabilities
1,365.10
1,635.36
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
371.63
275.83
Short Term Borrowings
923.04
704.40
1,090.85
934.11
1,625.60
0.00
3.32
319.07
210.43
124.62
Short Term Provisions
452.51
485.05
453.70
493.21
376.65
301.80
199.66
230.81
163.39
242.46
Total Liabilities
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
Net Block
6,422.65
7,064.63
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
Gross Block
10,728.19
10,511.53
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
Accumulated Depreciation
4,031.06
3,446.90
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
544.70
458.33
Non Current Assets
7,311.54
8,129.77
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
Capital Work in Progress
629.82
889.38
711.93
617.12
646.94
519.49
1,041.58
678.33
534.11
285.28
Non Current Investment
42.33
42.09
2.09
2.09
0.09
0.09
0.09
0.06
0.03
0.03
Long Term Loans & Adv.
166.55
96.84
222.19
150.58
130.96
182.32
99.66
206.92
129.47
62.84
Other Non Current Assets
50.19
36.83
126.28
196.03
72.22
122.40
85.25
50.28
60.74
23.90
Current Assets
5,294.65
5,523.22
4,980.92
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
Current Investments
183.98
139.05
0.02
351.35
492.27
803.55
779.59
297.59
185.63
60.44
Inventories
2,462.32
2,681.20
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
Sundry Debtors
1,632.48
1,523.37
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
Cash & Bank
403.41
603.50
666.65
816.04
867.23
893.72
647.03
567.36
769.42
626.97
Other Current Assets
612.46
512.69
443.21
405.83
683.16
672.16
459.34
532.03
343.95
261.80
Short Term Loans & Adv.
67.13
63.41
73.48
93.46
95.39
82.62
90.18
109.09
84.95
75.95
Net Current Assets
879.56
631.60
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
Total Assets
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
1,802.99
2,005.35
1,392.91
1,798.08
894.15
1,008.84
2,742.12
810.20
599.42
153.48
PBT
1,225.91
1,526.26
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
843.98
581.60
Adjustment
1,349.95
992.84
876.21
1,418.19
606.92
430.27
552.44
337.96
136.79
126.13
Changes in Working Capital
-351.85
-338.25
-385.83
99.39
-360.16
-125.21
423.58
-409.38
-119.68
-421.75
Cash after chg. in Working capital
2,224.01
2,180.85
1,676.95
2,079.24
1,177.77
1,393.15
3,319.46
868.39
861.09
285.98
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-421.02
-175.50
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-196.63
-449.42
198.61
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
Net Fixed Assets
-29.00
-198.83
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
Net Investments
-53.72
-179.03
351.33
138.83
310.79
-17.69
-484.32
-111.97
-131.60
287.55
Others
-113.91
-71.56
226.08
230.63
-772.52
-177.21
117.89
216.24
83.80
-73.97
Cash from Financing Activity
-1,781.05
-1,650.79
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
Net Cash Inflow / Outflow
-174.69
-94.86
42.48
242.35
-395.41
29.02
469.12
-139.85
330.01
-68.49
Opening Cash & Equivalents
572.56
661.82
588.76
702.04
1,067.57
1,049.86
612.38
955.05
687.41
760.80
Closing Cash & Equivalent
398.40
572.56
661.82
940.06
702.04
1,067.57
1,049.86
864.95
955.05
687.41

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
175.87
172.45
284.99
279.15
273.11
257.04
206.46
147.16
112.41
84.02
ROA
5.92%
9.20%
7.50%
3.15%
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
ROE
13.18%
23.49%
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
ROCE
14.35%
17.62%
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
Fixed Asset Turnover
1.43
1.43
1.48
1.50
1.57
1.35
1.82
1.88
3.11
2.60
Receivable days
37.86
38.92
37.65
33.78
35.74
74.66
82.76
105.19
77.81
68.65
Inventory Days
61.71
59.24
49.84
49.01
57.16
90.90
66.19
81.17
84.02
82.53
Payable days
306.08
383.19
133.47
139.05
150.99
171.27
204.35
176.11
158.58
143.69
Cash Conversion Cycle
-206.50
-285.04
-45.98
-56.26
-58.09
-5.72
-55.41
10.25
3.25
7.50
Total Debt/Equity
0.68
0.83
1.21
1.28
1.40
0.58
0.67
1.10
0.59
0.49
Interest Cover
5.81
5.32
3.63
2.11
4.02
6.29
13.74
6.37
15.40
18.21

News Update:


  • Torrent Pharmaceuticals reports 14% rise in Q3 consolidated net profit
    27th Jan 2023, 12:50 PM

    Total consolidated income of the company increased by 15.07% to Rs 2481 crore for Q3FY23

    Read More
  • Torrent Pharmaceuticals enters into partnership with Boehringer Ingelheim India
    14th Dec 2022, 16:00 PM

    Empagliflozin is a novel sodium glucose co-transporter-2 inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus

    Read More
  • Torrent Pharmaceuticals raises Rs 500 crore through NCDs
    10th Nov 2022, 11:00 AM

    Date of maturity of said NCDs will be 7 years from date of allotment

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.